Trial intelligence / Profile preview

Surufatinib in Advanced Neuroendocrine Tumors (Safety, PK, and Efficacy)

CTR20140735Phase 2Completed

Sponsor

HUTCHMED

Start

Oct 2014

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1